Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Anton

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Medicina Clinica|September 3, 2017
Pulmonary toxicity by riluzoleCoral González-Fernández, Rosa Güell, Antonio Anton
Respiration; International Review of Thoracic Diseases|October 1, 2010
Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapyJulia Tarrega, Antonio Anton, Rosa Guell, et al.
Oncology Letters|June 20, 2014
Brain metastasis in basaloid undifferentiated anal carcinoma: A case reportJorge Hernando-Cubero, Vicente Alonso-Orduña, Alba Hernandez-Garcia, et al.
Journal of Pain Research|December 4, 2012
Breakthrough cancer pain - still a challengeCesar Margarit, Joaquim Juliá, Rafael López, et al.
The European Respiratory Journal|July 7, 2017
Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trialJacobo Sellares, Miquel Ferrer, Antonio Anton, et al.
Anticancer Research|July 24, 2010
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancerAntonio Anton, Ana Lluch, Antonio Casado, et al.
Oncology Letters|December 2, 2015
Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case reportAna Cebollero DE Miguel, Roberto Pazo Cid, Javier Martinez Trufero, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Cancers|March 11, 2023
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx StudyAntonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2020
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysisSalvador Fudio, Josep Tabernero, Vivek Subbiah, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Medicina Clinica|September 3, 2017
Pulmonary toxicity by riluzoleCoral González-Fernández, Rosa Güell, Antonio Anton
Respiration; International Review of Thoracic Diseases|October 1, 2010
Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapyJulia Tarrega, Antonio Anton, Rosa Guell, et al.
Oncology Letters|June 20, 2014
Brain metastasis in basaloid undifferentiated anal carcinoma: A case reportJorge Hernando-Cubero, Vicente Alonso-Orduña, Alba Hernandez-Garcia, et al.
Journal of Pain Research|December 4, 2012
Breakthrough cancer pain - still a challengeCesar Margarit, Joaquim Juliá, Rafael López, et al.
The European Respiratory Journal|July 7, 2017
Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trialJacobo Sellares, Miquel Ferrer, Antonio Anton, et al.
Anticancer Research|July 24, 2010
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancerAntonio Anton, Ana Lluch, Antonio Casado, et al.
Oncology Letters|December 2, 2015
Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case reportAna Cebollero DE Miguel, Roberto Pazo Cid, Javier Martinez Trufero, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Cancers|March 11, 2023
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx StudyAntonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2020
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysisSalvador Fudio, Josep Tabernero, Vivek Subbiah, et al.
Pageof 2